Parexel is one of the world's largest clinical research organizations (CROs), providing Phase I-IV clinical development services to speed lifesaving treatments to patients. With over 21,000 professionals worldwide, we partner with biopharma leaders and innovators to design and deliver patient-focused trials, making clinical research accessible. For 40 years, we've advanced research in complex healthcare areas, offering innovative, efficient trial solutions. Recognized as a top CRO, Parexel won “Best CRO” by Citeline, “Top CRO to Work With” by WCG CenterWatch, and the 2023 SCRS Eagle Award for advancing clinical research.
Parexel is one of the world's largest clinical research organizations (CROs), providing Phase I-IV clinical development services to speed lifesaving treatments to patients. With over 21,000 professionals worldwide, we partner with biopharma leaders and innovators to design and deliver patient-focused trials, making clinical research accessible. For 40 years, we've advanced research in complex healthcare areas, offering innovative, efficient trial solutions. Recognized as a top CRO, Parexel won “Best CRO” by Citeline, “Top CRO to Work With” by WCG CenterWatch, and the 2023 SCRS Eagle Award for advancing clinical research.
Parexel is one of the world's largest clinical research organizations (CROs), providing Phase I-IV clinical development services to speed lifesaving treatments to patients. With over 21,000 professionals worldwide, we partner with biopharma leaders and innovators to design and deliver patient-focused trials, making clinical research accessible. For 40 years, we've advanced research in complex healthcare areas, offering innovative, efficient trial solutions. Recognized as a top CRO, Parexel won “Best CRO” by Citeline, “Top CRO to Work With” by WCG CenterWatch, and the 2023 SCRS Eagle Award for advancing clinical research.